1Pharmaceutical Research Institute, Bristol-Myers Squibb, Princeton 08543-4000, USA. leonard.sigal@bms.com
The NF-kappaB protein family acts as a crucial intracellular bottleneck for inflammatory signaling, offering a potential therapeutic target for autoimmune diseases like rheumatoid arthritis. Understanding its control mechanisms is key for developing new treatments.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: